Castle Biosciences Inc.

NASDAQ: CSTL · Real-Time Price · USD
20.11
0.29 (1.46%)
At close: Aug 15, 2025, 12:35 PM

Castle Biosciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
86.19M 87.99M 86.31M 85.78M 87M 72.97M 66.12M 61.49M 50.14M 42.04M 38.34M 37.01M 34.84M 26.85M 25.04M 23.48M 22.76M 22.81M
Cost of Revenue
20.13M 16.38M 16.18M 15.61M 17.23M 16.58M 15.09M 11.32M 11.06M 10.18M 9.52M 8.86M 7.69M 5.94M 4.6M 4.5M 3.7M 3.03M
Gross Profit
66.06M 71.61M 70.13M 70.17M 69.77M 56.4M 51.03M 50.17M 39.08M 31.86M 28.82M 28.15M 27.15M 20.91M 20.44M 18.98M 19.06M 19.79M
Operating Income
-4.25M -27.93M 4.05M 5.08M 5.01M -5.47M -5.66M -9.64M -21.16M -31.52M -23.13M -21.69M -24.37M -24.52M -15.17M -11.81M -8.81M -4.28M
Interest Income
2.94M 3.1M 3.37M 3.4M 3.14M 3M 3.12M 2.77M 2.4M 2.34M 2.27M 1.29M 370K 30K 17K 23K 24K 4K
Pretax Income
-143K -26.27M 7.88M 8.28M 7.89M -2.49M -2.54M -6.87M -18.76M -29.19M -20.56M -20.25M -3.6M -24.49M -15.15M -11.79M -8.79M -4.28M
Net Income
4.52M -25.85M 9.59M 2.27M 8.92M -2.53M -2.58M -6.91M -18.78M -29.2M -20.62M -18.81M -1.65M -24.62M -6.43M -11.79M -8.79M -4.28M
Selling & General & Admin
58.06M 58.62M 49.97M 50.5M 50.71M 48.41M 43.77M 44.62M 44.68M 46.76M 38.43M 36.63M 37.5M 30.45M 25.16M 22.59M 20.82M 18.16M
Research & Development
12.79M 12.59M 11.68M 12.32M 14.05M 13.46M 12.91M 12.92M 13.31M 14.39M 11.31M 10.91M 11.93M 10.76M 9.45M 7.5M 6.79M 5.91M
Other Expenses
-544K 28.32M 4.44M 2.27M n/a n/a n/a 2.27M 2.25M 2.22M 2.21M 2.31M 2.1M 4.21M 5.61M 694K 256K n/a
Operating Expenses
70.31M 99.53M 66.08M 65.09M 64.76M 61.87M 56.68M 59.81M 60.24M 63.38M 51.95M 49.84M 51.52M 45.42M 35.61M 30.79M 27.87M 24.07M
Interest Expense
21K -17K 92K 201K 270K 14K 2K 2K 3K 4K 4K 6K 4K 3K 1K n/a n/a n/a
Selling & Marketing Expenses
n/a 36.81M 30.41M 29.84M 32.67M 30.54M 26.96M 28.5M 28.25M 29.95M -43.97M 22.39M 21.58M n/a n/a n/a n/a n/a
Cost & Expenses
90.44M 115.92M 82.26M 80.7M 81.99M 78.44M 71.78M 71.13M 71.3M 73.56M 61.47M 58.7M 59.21M 51.37M 40.21M 35.29M 31.57M 27.1M
Income Tax Expense
-4.67M -423K -1.71M 6.01M -1.03M 45K 39K 32K 16K 14K 57K -1.44M -1.96M 134K -8.72M 23K 5K 4K
Shares Outstanding (Basic)
28.91M 28.61M 28.13M 27.84M 27.65M 27.48M 27.03M 26.83M 26.73M 26.61M 26.4M 26.3M 26.06M 25.42M 25.33M 25.29M 25.09M 24.91M
Shares Outstanding (Diluted)
29.55M 28.61M 30.2M 29.4M 28.74M 27.48M 27.03M 26.83M 26.73M 26.61M 26.4M 26.32M 26.06M 25.42M 25.33M 25.29M 25.09M 24.91M
EPS (Basic)
0.16 -0.9 0.34 0.08 0.32 -0.09 -0.1 -0.26 -0.7 -1.1 -0.78 -0.72 -0.06 -0.97 -0.25 -0.47 -0.35 -0.17
EPS (Diluted)
0.15 -0.9 0.32 0.08 0.31 -0.09 -0.1 -0.26 -0.7 -1.1 -0.78 -0.71 -0.06 -0.97 -0.25 -0.47 -0.35 -0.17
EBITDA
-4.25M 3.51M 13.74M 12.02M 11.5M 865K 685K -3.7M -15.72M -26.29M -17.72M -17.32M -973K -22.34M -13.7M -10.7M -8.15M -4.05M
EBIT
-122K -26.29M 7.98M 8.48M 5.01M -2.48M -2.54M -6.87M -18.76M -29.19M -20.56M -20.24M -3.6M -24.49M -15.15M -11.79M -8.79M -4.28M
Depreciation & Amortization
3.41M 29.76M 5.77M 3.54M 3.35M 3.34M 3.22M 3.17M 3.04M 2.89M 2.84M 2.92M 2.63M 2.15M 1.45M 1.09M 634K 233K